Alkermes (ALKS) Tops Q4 EPS by 3c, Offers Guidance
Get Alerts ALKS Hot Sheet
Price: $46.10 -1.66%
EPS Growth %: -108.2%
Financial Fact:
Basic and diluted: -95.48M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -108.2%
Financial Fact:
Basic and diluted: -95.48M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q4 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the quarter came in at $280 million versus the consensus estimate of $268.25 million.
GUIDANCE:
Alkermes sees 2021 EPS of $0.37-$0.62, versus the consensus of $0.52. Alkermes sees 2021 revenue of $1-1.17 billion, versus the consensus of $1.12 billion.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share